Literature DB >> 11461738

Propranolol treatment of congestive heart failure in infants with congenital heart disease: The CHF-PRO-INFANT Trial. Congestive heart failure in infants treated with propanol.

R Buchhorn1, M Hulpke-Wette, R Hilgers, D Bartmus, A Wessel, J Bürsch.   

Abstract

AIM: Infants with congenital heart disease and left-to-right shunts may develop significant clinical symptoms of congestive heart failure in spite of therapy with digoxin and diuretics. We investigated the effects of beta-blockade in infants with severe heart failure. METHODS AND
RESULTS: We performed a prospective, randomized, open monocenter trial in infants treated with digoxin and diuretics (n=10) in comparison to 10 infants receiving additional beta-blocker therapy. After 17 days on average beta-blocker treated infants (propranolol:1,6 mg/kg/day) improved significantly with respect to Ross heart failure score (3.3+/-2.3 vs. 8.3+/-1.9, P=0.002), lower renin levels (338+/-236 vs. 704+/-490 microU/l, P=0.008) and lower mean heart rates in Holter ECG (118+/-10 vs. 142+/-11 beats/min, P<0.001). While digoxin and diuretic treated infants had unchanged mean heart rate (149+/-8 vs. 148+/-10 beats/min), less decrease of symptoms (Ross Score: 8.5+/-1.7 vs. 6.8+/-2.3, P=0.02) but a significant increase of renin levels (139+/-102 vs. 938+/-607 microU/l, P=0.001).
CONCLUSION: Additional propranolol treatment but not digoxin and diuretics alone can effectively reduce clinical symptoms of heart failure in infants with congenital heart disease, who suffer from increased neurohormonal activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461738     DOI: 10.1016/s0167-5273(01)00413-2

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

Review 1.  Approach to a Child with Congestive Heart Failure.

Authors:  Manojkumar Rohit; Sudhansu Budakoty
Journal:  Indian J Pediatr       Date:  2020-04       Impact factor: 1.967

Review 2.  Should beta-blockers be used for the treatment of pediatric patients with chronic heart failure?

Authors:  Luke A Bruns; Charles E Canter
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

3.  Role of β-blocker therapy in pediatric heart failure.

Authors:  Akash R Patel; Robert E Shaddy
Journal:  Ped Health       Date:  2010

Review 4.  Advances in heart failure therapy in pediatric patients with dilated cardiomyopathy.

Authors:  Stefan Rupp; Christian Jux
Journal:  Heart Fail Rev       Date:  2018-07       Impact factor: 4.214

Review 5.  Drug Treatment of Heart Failure in Children: Gaps and Opportunities.

Authors:  Molly Weisert; Jennifer A Su; Jondavid Menteer; Robert E Shaddy; Paul F Kantor
Journal:  Paediatr Drugs       Date:  2022-01-27       Impact factor: 3.022

Review 6.  Pediatric heart failure therapy with beta-adrenoceptor antagonists.

Authors:  Susan R Foerster; Charles E Canter
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

7.  Beta-blocker therapy and hemophagocytic lymphohistiocytosis: a case report.

Authors:  C Müller; L B Mänhardt; C Willaschek; E M Schneider; E A Stuth; R Buchhorn
Journal:  Cardiol Res Pract       Date:  2010-06-20       Impact factor: 1.866

8.  Effect of Carvedilol on QT Duration in Paediatric Patients with Congestive Heart Failure.

Authors:  Thomas S Mir; Stephanie Läer; Michele Eiselt; Jan Falkenberg; Urda Gottschalk; Jochen Weil
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

Review 9.  "Nihilism" of chronic heart failure therapy in children and why effective therapy is withheld.

Authors:  Dietmar Schranz; Norbert F Voelkel
Journal:  Eur J Pediatr       Date:  2016-02-19       Impact factor: 3.183

10.  Efficacy and safety of propranolol in infants with heart failure due to moderate-to-large ventricular septal defect (VSD-PHF study) - A prospective randomized trial.

Authors:  Sivasubramanian Ramakrishnan; Nirmal Ghati; Ramandeep Singh Ahuja; Kinjal Niranjan Bhatt; Hem Chandra Sati; Anita Saxena; Shyam Sunder Kothari
Journal:  Ann Pediatr Cardiol       Date:  2021-08-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.